Who is Dr. Burzynski?

Dr. Burzynski is a renowned physician and researcher, who pioneered the use of biologically active peptides for cancer treatment. Graduating top of his class in 1967 from the Medical Academy in Lublin, Poland, he identified human peptides deficient in cancer patients, suggesting their role in inhibiting cancer cell growth.

In 1977, he established the Burzynski Clinic in Houston, Texas, where over 10,000 patients, including 2,300 cancer patients, participated in FDA-reviewed clinical trials using Antineoplastons, derived from his peptide research. Dr. Burzynski's extensive work, encompassing over 300 scientific publications and collaborations with institutions worldwide, has led to patents in 35 countries and membership in esteemed medical organizations, reflecting his contributions to cancer research and treatment.